LATEST NEWS
Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants
EXACT Therapeutics announces grant of core patent in the U.S.
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer

